Dissemin is shutting down on January 1st, 2025

Published in

Taylor and Francis Group, Clinical Lipidology, 1(8), p. 151-157, 2013

DOI: 10.2217/clp.12.90

Links

Tools

Export citation

Search in Google Scholar

Comparative study of high-dose Xuezhikang and low-dose Xuezhikang plus ezetimibe on pro- and anti-inflammatory markers

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Red circle
Preprint: archiving forbidden
Red circle
Postprint: archiving forbidden
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO